Wahed Invest LLC Acquires 43 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Wahed Invest LLC grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,786 shares of the biotechnology company’s stock after purchasing an additional 43 shares during the quarter. Wahed Invest LLC’s holdings in Axon Enterprise were worth $1,061,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Friedenthal Financial raised its position in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after acquiring an additional 1,231 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Axon Enterprise by 33.1% in the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after purchasing an additional 33,869 shares during the period. Artemis Investment Management LLP lifted its stake in Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after purchasing an additional 16,792 shares during the last quarter. Decker Retirement Planning Inc. bought a new position in Axon Enterprise during the fourth quarter valued at $2,985,000. Finally, MRA Advisory Group increased its position in Axon Enterprise by 64.4% in the fourth quarter. MRA Advisory Group now owns 3,205 shares of the biotechnology company’s stock worth $1,905,000 after buying an additional 1,255 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Stock Up 1.3 %

AXON opened at $621.10 on Friday. The firm has a market capitalization of $48.35 billion, a P/E ratio of 160.49, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a fifty day moving average price of $551.54 and a 200-day moving average price of $575.64. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 23rd. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Finally, The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $626.45.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.